| PMID: |
Species: |
ncRNA Symbol: |
Diseases: |
Description the function of ncRNA: |
Details: |
|
20676061
|
Homo sapiens
|
hsa-miR-129-3p
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-133a
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-149
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-197
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-204
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1237
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-191*
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1228
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-296-5p
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-101
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-365
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-21*
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-933
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-539
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1229
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1238
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-301a
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-130b
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-10b
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-206
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-363
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-513b
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-140-5p
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-126
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-451
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-100
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1234
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1236
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-106b
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-143
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-26a
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-26b
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-29c
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-33b*
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-338-3p
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-520b
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-505
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-1225-3p
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-miR-550
|
Dupuytren's disease
|
In Dupuytren's contracture samples compared with control samples, 65 miRNAs were significantly downregulated (q<0.05; fold change>2.0)
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-648
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-373*
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-let-7d
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-205
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-200a*
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-34c-3p
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-423-3p
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-551b*
|
Dupuytren's disease
|
Exclusively and preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-934
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-23a*
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-617
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-382
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-498
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-519e
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-584
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-631
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-181d
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-30b*
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
20676061
|
Homo sapiens
|
hsa-mir-936
|
Dupuytren's disease
|
Preferentially expressed miRNAs (q-value <0.05) in Dupuytren's contracture samples
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-21-5p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-320a
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-22-3p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-378a-3p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-let-7b-5p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-134
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-381-3p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-452-5p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-let-7f-5p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-27b-3p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
26446724
|
Homo sapiens
|
hsa-miR-139-5p
|
Dupuytren's disease
|
MicroRNAs differentially expressed between Dupuytren’s and control palmar fascia
|
Detail
|
|
27607190
|
Homo sapiens
|
hsa-miR-374a-5p
|
Dabetic Foot Ulcers
|
Upon compaRattus norvegicusive analyses among 3 DFUF and 3 NFF cell lines, we found a total of 21 miRNAs differentially expressed with p<0.05 and fold change ≥2.0. Of these, 11 miRNAs were up-regulated and 10 miRNAs were down-regulated in DFUFs
|
Detail
|
|
27607190
|
Homo sapiens
|
hsa-miR-132-3p
|
Dabetic Foot Ulcers
|
Upon compaRattus norvegicusive analyses among 3 DFUF and 3 NFF cell lines, we found a total of 21 miRNAs differentially expressed with p<0.05 and fold change ≥2.0. Of these, 11 miRNAs were up-regulated and 10 miRNAs were down-regulated in DFUFs
|
Detail
|
|
27607190
|
Homo sapiens
|
hsa-miR-1468
|
Dabetic Foot Ulcers
|
Upon compaRattus norvegicusive analyses among 3 DFUF and 3 NFF cell lines, we found a total of 21 miRNAs differentially expressed with p<0.05 and fold change ≥2.0. Of these, 11 miRNAs were up-regulated and 10 miRNAs were down-regulated in DFUFs
|
Detail
|
|
27607190
|
Homo sapiens
|
hsa-miR-605
|
Dabetic Foot Ulcers
|
Upon compaRattus norvegicusive analyses among 3 DFUF and 3 NFF cell lines, we found a total of 21 miRNAs differentially expressed with p<0.05 and fold change ≥2.0. Of these, 11 miRNAs were up-regulated and 10 miRNAs were down-regulated in DFUFs
|
Detail
|
